A comprehensive review of remimazolam for sedation [PDF]
Health Psychology Research, 2021 Benzodiazepines are one of the most commonly used medications in the field of anesthesia. They offer excellent anxiolytic and amnestic properties ideal for the perioperative period when patient anxiety is understandably heightened. Remimazolam has presented a favorable alternative to some of the common intravenous anesthetic agents used given its fast ...
Nazir Noor +5 more
openaire +3 more sources
Remimazolam-induced intracellular calcium elevation in HEK293 cells.
, 2022 (A) Remimazolam at a concentration greater than or equal to 300 μM significantly induced the elevation of intracellular calcium in a dose-dependent manner in HEK293 cells. (n = 3–5, * p (TIF)
Soma Noguchi (12029730) +8 more
core +1 more source
Three cases of difficulty in achieving definitive loss of consciousness with remimazolam
JA Clinical Reports, 2022 Background Remimazolam is a novel, ultra-short-acting benzodiazepine used for general anesthesia. Because remimazolam is an emerging drug, the tolerance to remimazolam in benzodiazepine-taking patients has been unclear.
Mao Miyanishi +3 more
doaj +1 more source
Remimazolam-induced intracellular calcium elevation in SHSY-5Y cells and HUVECs.
, 2022 (A) Remimazolam at a concentration greater than or equal to 300 μM significantly induced the elevation of intracellular calcium in a dose-dependent manner in SHSY-5Y cells (n = 3–7, * p < 0.05, compared to control, one-way ANOVA followed by Dunnett’s ...
Soma Noguchi (12029730) +8 more
core +1 more source
Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study [PDF]
Korean Journal of AnesthesiologyBackground Minimalist transcatheter aortic valve replacement (TAVR) under monitored anesthesia care (MAC) emphasizes early recovery. Remimazolam is a novel benzodiazepine with a short recovery time.
Ji-Hyeon Kim +7 more
doaj +1 more source
Remimazolam anesthesia for cardiac surgery with cardiopulmonary bypass: a case report
JA Clinical Reports, 2021 Background Remimazolam has less cardiovascular depressant effects than propofol in non-cardiac surgical patients. However, the efficacy and safety of remimazolam in cardiac surgery with cardiopulmonary bypass (CPB) have not been reported.
Kota Saito +4 more
doaj +1 more source
Comparison of postoperative nausea and vomiting between remimazolam and propofol: a propensity score-matched, retrospective, observational, single-center cohort study [PDF]
Korean Journal of Anesthesiology, 2023 Background Remimazolam is a novel ultrashort-acting benzodiazepine that has recently become available for general anesthesia. However, the incidence of postoperative nausea and vomiting (PONV) associated with remimazolam remains unknown.
Yuji Suzuki +4 more
doaj +1 more source
Anesthetic management with remimazolam in a patient with Child-Pugh C liver cirrhosis: a case report
JA Clinical Reports, 2022 Background Remimazolam is a new ultra-short-acting benzodiazepine, and its sedative effect is prolonged in patients with hepatic impairment. This is the first report of remimazolam anesthesia in a patient with Child-Pugh C liver cirrhosis.
Satoshi Uchida +4 more
doaj +1 more source
Frontiers in Medicine, 2022 ObjectiveHypotension is common in propofol anesthesia. Whether remimazolam could reduce intraoperative hypotension remains unknown. We therefore tested the primary hypothesis that remimazolam reduces the incidence of intraoperative hypotension compared ...
Yuwei Qiu +6 more
doaj +1 more source
Medicina, 2023 Background: Remimazolam besylate, a newly developed drug, is linked to various anaphylaxis cases. We present a case of remimazolam anaphylaxis confirmed using a provocation test.
Sangho Lee +7 more
doaj +1 more source